By Lawrence Dunhill2020-12-21T18:00:00
Multiple failings have been identified in how a leading cancer trust entered into a £20m research partnership with a large pharmaceutical company, and how bosses then reacted to concerns raised by staff.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud